PositiveDouble Blind Clinical Trial2023
Examining the use of cannabidiol and delta-9-tetrahydrocannabinol-based medicine among individuals diagnosed with dementia living within residential aged care facilities: Results of a double-blind randomised crossover trial
Classification Results
AI Classification
PositiveFine-tuned Classification
Positive